PetLife Pharmaceuticals, Inc. - FORM 10-Q - EX-32.2 - CERTIFICATION REQUIRED BY 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 SIGNED BY CHIEF FINANCIAL OFFICER - July 23, 2012

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - PetLife Pharmaceuticals, Inc.Financial_Report.xls
10-Q - ECO VENTURES GROUP, INC. FORM 10-Q MAY 31, 2012 - PetLife Pharmaceuticals, Inc.ecoventures10q20120531.htm
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14 OR 15D-14 OF THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 SIGNED BY THE PRINCIPAL FINANCIAL OFFICER - PetLife Pharmaceuticals, Inc.ex31-2.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14 OR 15D-14 OF THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 SIGNED BY THE PRINCIPAL EXECUTIVE OFFICER - PetLife Pharmaceuticals, Inc.ex31-1.htm
EX-32.1 - CERTIFICATION REQUIRED BY 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 SIGNED BY PRINCIPAL EXECUTIVE OFFICER - PetLife Pharmaceuticals, Inc.ex32-1.htm
 
Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
 (Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002)
 
In connection with the Quarter Report on Form 10-Q for the three months ended May 31, 2012 of Eco Ventures Group, Inc. (the “Company”) as filed with the Securities and Exchange Commission on the date hereof (the “Report”) and pursuant to 18. U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Randall Lanham, Chief Executive Officer of the Company, certify, that to my knowledge:
 
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
 
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

   
 
/s/ RANDALL LANHAM
 
  Randall Lanham
 
Chief Executive Officer
 
July 23, 2012
 
     
Note:
  
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
 

PetLife Pharmaceuticals, Inc. Reports